Brief Reports
Copyright ©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 7, 2005; 11(25): 3915-3919
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3915
Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells
Tong Xu, Bao-Cun Sun, Qiang Li, Xi-Shan Hao
Tong Xu, Qiang Li, Xi-Shan Hao, Department of Abdominal Surgery, Cancer Hospital Affiliated to Tianjin Medical University, Tianjin 300060, China
Bao-Cun Sun, Institute of Oncology, Tianjin Medical University, Tianjin 300060, China
Author contributions: All authors contributed equally to the work.
Supported by the Science and Technology Commission Foundation of Tianjin, No. 003119711
Correspondence to: Dr. Tong Xu, Department of Abdominal Surgery, Cancer Hospital Affiliated to Tianjin Medical University, Tianjin 300060, China. tong_xu@126.com
Telephone: +86-22-23537796 Fax: +86-22-23359984
Received: August 18, 2004
Revised: November 15, 2004
Accepted: November 19, 2004
Published online: July 7, 2005
Abstract

AIM: To investigate the potential role of cytokines in promoting Fas ligand (FasL)-expressing colon cancer cells.

METHODS: Immunohistochemical SABC method was used to observe the expression of Fas receptor and ligand in SW620 colon cancer cell line and Jurkat T cells in order to provide the morphological evidence for the functions of Fas receptor and ligand. To examine the cytotoxicity of effector cells, CytoTox96 non-radioactive cytotoxicity assay was adopted to measure the lactate dehydrogenase-releasing value after SW620 cells were co-cultured with Jurkat T lymphocytes.

RESULTS: The FasL of colon cancer SW620 cells was positive. The positive substances were distributed in the cell membrane and cytoplasm. The Fas receptor of colon cancer SW620 cells was negative. The Fas receptor and ligand of Jurkat T lymphocytes turned out to be positive. The positive substances were distributed in the cell membrane. After phytohemagglutinin (PHA)-stimulated Jurkat T lymp-hocytes were co-cultured with phorbol 12-myristate 13-acetate (PMA)-plus-ionomycin-stimulated (for 48 h) SW620 cells or tumor necrosis factor-alpha (TNF-α)-stimulated (for 48 h) SW620 cells or unstimulated SW620 cells for 4 h, the cytotoxicity of SW620 cells to PHA-stimulated Jurkat cells at effector-to-target ratios of 10:1, 5:1, 2.5:1, and 1.25:1 was 74.6%, 40.8%, 32.4%, and 10.9% (F = 8.19, P < 0.05); or 54.9%, 35.3%, 22.0%, and 10.3% (F = 11.12, P < 0.05); or 14.9%, 10.5%, 6.9%, and 5.8% (F = 3.45, P < 0.05). After PHA-stimulated Jurkat T lymphocytes were co-cultured with unstimulated SW620 cells for 8 h, the cytotoxicity of SW620 cells to PHA-stimulated Jurkat cells at effector-to-target ratios of 5:1, 2.5:1, and 1.25:1 from the experiment was 83.9%, 74.1%, and 28.5% (F = 137.04, P < 0.05) respectively. Non-radioactive cytotoxicity assay showed that the apoptotic rate of Jurkat cells remarkably increased with the increase of planting concentration of SW620 cells and co-culture time after the SW620 cells were co-cultured with the Jurkat T lymphocytes. The cytotoxicity was significantly enhanced by PMA+ionomycin or TNF-α.

CONCLUSION: The FasL expressed in human colon cancer cells may be regulated by endogenous factors in the microenvironment of the host and facilitate the escape of tumor cells from the host immune system.

Keywords: Cytokines, Fas/Fas ligand, Colon cancer, Apoptosis, Immune escape